Kiniksa Pharmaceuticals International, plc

KNSA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001730430

SEC filings (opens in a new tab)

In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Kiniksa Pharmaceuticals International, plc changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of KNSA: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Of which not filed for Q4 2023	Q4 2023	Change
Holders	134	1	142	+9
Shares	34.9M	25.2K	34.2M	−619.5K (−1.8%)
Value	$605.8M	$437.7K	$600.4M	−$4.94M (−0.8%)

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to KNSA in Q4 2023
Institution	Shares	Value	% of portfolio
Altitude Crest Partners Inc.	456,041	$8.00M	5.35%
Walleye Capital LLC	327,332	$5.74M	0.08%
StemPoint Capital LP	183,102	$3.21M	0.87%
Logos Global Management LP	150,000	$2.63M	0.29%
ADAR1 Capital Management, LLC	105,000	$1.84M	0.82%
HighVista Strategies LLC	88,688	$1.56M	0.56%
ExodusPoint Capital Management, LP	83,572	$1.47M	0.02%
HRT Financial LP	74,866	$1.31M	0.01%
Jump Financial, LLC	54,220	$951.0K	0.03%
Balyasny Asset Management LLC	46,289	$811.9K	0.00%
Opaleye Management Inc.	37,500	$640.2K	0.17%
Cubist Systematic Strategies, LLC	35,916	$630.0K	0.01%
Janney Montgomery Scott LLC	24,903	$437.0K	0.00%
Point72 Middle East FZE	24,218	$424.8K	0.03%
Walleye Trading LLC	21,424	$375.8K	0.01%
SG Americas Securities, LLC	17,725	$311.0K	0.00%
MetLife Investment Management	17,349	$304.3K	0.00%
Fox Run Management, L.L.C.	12,546	$220.1K	0.06%
Y-Intercept (Hong Kong) Ltd	12,180	$213.6K	0.02%
Dynamic Technology Lab Private Ltd	12,160	$213.0K	0.02%
Aquatic Capital Management LLC	8,600	$151.0K	0.00%
State of Wyoming	2,342	$41.1K	0.01%
EntryPoint Capital, LLC	1,743	$30.6K	0.03%
GAMMA Investing LLC	781	$13.8K	0.00%
Newbridge Financial Services Group, Inc.	300	$5.26K	0.00%
Fortitude Family Office, LLC	249	$4.37K	0.00%
Planned Solutions, Inc.	200	$3.51K	0.00%
Robeco Institutional Asset Management B.V.	119	$2.09K	0.00%
The PNC Financial Services Group, Inc.	6	$105	0.00%

Sold out (20)

Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of KNSA in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)	698,741	$12.1M
Marshall Wace, LLP	158,230	$2.75M
Soleus Capital Management, L.P.	157,349	$2.73M
EAM Investors, LLC	124,438	$2.16M
AlphaCentric Advisors LLC	110,000	$1.91M
Jackson Creek Investment Advisors LLC	65,607	$1.14M
Dark Forest Capital Management LP	65,029	$1.13M
Gsa Capital Partners LLP	63,216	$1.10M
Capula Management Ltd	51,340	$891.8K
Winton Group Ltd	22,504	$390.9K
Russell Investments Group, Ltd.	20,814	$362.6K
SEI Investments Co	20,819	$361.6K
Nebula Research & Development LLC	13,686	$237.7K
Engineers Gate Manager LP	10,326	$179.4K
Globeflex Capital L P	9,338	$162.2K
Amundi	5,770	$94.1K
IFP Advisors, Inc	3,750	$65.1K
Lazard Asset Management LLC	3,502	$60.0K
Cary Street Partner Investment Advisory LLC	1,000	$17.4K
Toronto Dominion Bank	4	$69

Not filed for Q4 2023 yet (1)

Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KNSA in Q3 2023 that haven't filed for Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Virginia Retirement Systems Et Al	25,200	$437.7K